First-line therapy referenced by NSCL-30 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer, Version 6.2024 for treating ROS1 rearrangement is included for comparison. Here, ROS1 is linked to non-small cell lung carcinoma.